Eli Lilly’s stock plunges as investors eye obesity-drug competition 18 de julho de 2024 by in News Eli Lilly & Co.’s stock was on pace for its worst day in about three years Thursday as investors fretted about intensifying competition among obesity-drug developers. Compartilhe isso:Clique para compartilhar no Twitter(abre em nova janela)Clique para compartilhar no Facebook(abre em nova janela) Relacionado 18 de julho de 2024